<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" >
   <HEAD>
	<TITLE>NovoCIB's purified active nucleoside kinases - human adenosine kinase enzyme, human deoxycytidine kinase enzyme, human UMP-CMP kinase enzyme, human 5'-nucleotidase enzyme</TITLE>
	<!--[if IE 6]><meta http-equiv="Refresh" content="0; url=http://www.novocib.com/IE7/index.html"><![endif]-->
    <!--[if IE 7]><meta http-equiv="Refresh" content="0; url=http://www.novocib.com/IE7/index.html"><![endif]-->
    <META http-equiv=Content-Type content="text/html; charset=iso-8859-1">
	<META name=Title content="Human nucleoside kinases - adenosine kinase, deoxycytidine kinase, UMP-CMP kinase">
	<META name=Author content="NovoCIB (lbalakireva@novocib.com)">
	<META name=Subject content=">
	<META name=Description content="NovoCIB's provides a panel of cloned human nucleoside kinases critical for activation of nucleoside analogues by phosphorylation">
	<META name=Keywords content="Nucleoside metabolism enzyme"> 
	<META content=en name=Language>
	<META content=" name=Expires>
	<META content="NOVOCIB © 2006" name=Distribution>
	<META content=All name=Robots>
	   <!-- css -->
	   <LINK href="css/Stylesmaller.css" type=text/css rel=stylesheet>
	   <!-- favico -->
	   <LINK href="http://www.novocib.com/favicon.ico" rel="shortcut icon">
	   <link rel="stylesheet" media="screen" type="text/css" title="Style" href="css/Stylesmaller.css">
<!-- end favico -->

<!-- script du menu -->
<script type="text/javascript" src="JavMenu.js"></script>
 <!-- détéction du navigateur -->
<script type="text/javascript" src="navdetecteur.js"></script>

<!-- important pour que les vieux navigateurs ne comprennent pas le CSS -->
<style type="text/css">
    @import "Stylesmaller.css";
</style>

</head>
<body>
<div id="page">

<!--[if lt IE 8]><div align=left class="smallRed">This site is designed for IE 8 or IE 9. We are working for compatibility with lower versions. For better convenience, please visit us with IE 8, IE 9, Google Chrome or Firefox, or any other compatible navigator</div><![endif]-->

<!-- HEADER -->
<div id="header">
  <div id="headerLogo"><a href="http://www.novocib.com" title="NovoCIB Home Page"><img src="images/logo NovoCIB1.png" width="247" height="122"/></a></div>
    <p>&nbsp;
     </script>
<script src="//platform.linkedin.com/in.js" type="text/javascript">
 lang: en_US
</script>
<script type="IN/FollowCompany" data-id="5048147" data-counter="none"></script>
    <div id="headerSlogan"><SPAN class=ChapterThirdTitle><em>Reliable solutions for nucleotide assessment</em></SPAN><img src="images/HorizBarMenu.gif" width=380 /></div>
    <div><a href="http://www.novocib.com/contact" class=MenuContact title="Contact">Contact</a>&nbsp;&nbsp;</div> <br /><br />
</div>
<!-- End HEADER -->

<!-- SQUARE RIGHT -->
<div id="SquareRight" class="small">
  
  <div align="center" class=ChapterThirdTitle style4>Award</div>
  <div align=center>Dr Larissa Balakireva, CEO &amp; Founder of NovoCIB, was awarded with the Trophy of
      <br /><a href="http://www.aufeminin.com/evenement/femmes-en-or/" Title="Femmes en Or 2011" class="boldRedAct" target=_blank>"Femmes en Or 2011, Femme de l'Innovation"</a>
      <br />in September 2011
  </div>.
  <div align=center><a href="http://www.aufeminin.com/evenement/femmes-en-or/" Title="Femmes en Or 2011" class="boldRedAct" target=_blank><img src="images/trophees femmes en or.jpg"/ width=100 ></a>
  </div>
  
    
</div>
<!-- End SQUARE RIGHT -->



<!-- MENU PRINCIPAL, HORIZONTAL -->
<div id="menu">
  <ul id="MenuDeroul">
    <li><a href="Purified_Active_Enzymes.html"><strong>PURIFIED<br />
    ENZYMES</strong></a>
        <ul>
            <li><a href="Recombinant_Purine_Metabolism_Enzymes.html">Purine Metabolism Enzymes</a>
                <ul>
                    <li><a href="IMPDH_Recombinant_Enzyme.html">IMPDH Enzymes<br /><span class="ItemNameHoriz">Inosine Monophosphate Dehydrogenase</span></a>
                        <ul>
                            <li><a href="Human_Recombinant_IMPDH.html">Human IMPDH</a></li>
                            <li><a href="Bacterial_Recombinant_IMPDH.html">Bacterial IMPDH</a></li>
                        </ul>
                    </li>
                    <li><a href="Human_Recombinant_PNP.html">PNP Enzyme<br /><span class=ItemNameHoriz>Purine Nucleoside Phosphorylase</span></a></li>
                     <li><a href="Xanthine_Dehydrogenase_XDH.html">XDH Enzyme<br /><span class=ItemNameHoriz>Xanthine dehydrogenase</span></a></li>
                    <li><a href="Human_Recombinant_HGPRT.html">HGPRT Enzyme<br /><span class=ItemNameHoriz>Hypoxanthine-guanine phosphoribosyltransferase</span></a></li>
                </ul>
            </li>
            <li><a href="Recombinant_Nucleoside_Kinases.html">Nucleoside Kinase  Nucleotidase</a>
                <ul>
                    <li><a href="Recombinant_Adenosine_Kinase.html">ADK Enzyme<br /><span class=ItemNameHoriz>Adenosine Kinase</span></a></li>
                    <li><a href="Recombinant_Deoxycytidine_Kinase.html">dCK Enzyme<br /><span class=ItemNameHoriz>Deoxycytidine Kinase</span></a></li>
                    <li><a href="Recombinant_UMP-CMP_Kinase.html">CMK Enzyme<br /><span class=ItemNameHoriz>UMP-CMP Kinase</span></a></li>
                    <li><a href="Recombinant_5'-nucleotidase.html">cN-II Enzyme<br /><span class=ItemNameHoriz>cytosolic 5'-nucleotidase II</span></a>            </li>
                </ul>
            </li>
            <li><a href="Bacterial_Bioluminescence_Enzymes.html">Bacterial Bioluminescence Enzymes</a>
                <ul>
                    <li><a href="Bacterial_Luciferase.html">Bacterial Luciferase, Highly Pure<br /><span class="ItemNameHoriz">from <em>Photobacterium phosphoreum</em></span></a></li>
                    <li><a href="Bacterial_FMN_Reductase.html">FMN Reductase<br /><span class="ItemNameHoriz">for Bacterial Bioluminescence</span></a>            </li>
                </ul>
            </li>
      </ul>
    </li>
    <li><a href="Nucleotides_Life_Science.html"><strong>NUCLEOTIDES<br /> 
      LIFE SCIENCE<br />
    </strong></a>	
        <ul>
          <li><a href="Convenient_Assay_Kits.html">Assay Kits</a>
          <li><a href="Cellular_Nucleotides_Analysis.html">HPLC Analysis</a>
  </ul>
   <li><a href="Freshness_Assay_Kits.html"><strong>NUCLEOTIDES<br />
      FRESHNESS</strong></a>
       <ul>
              <li><a href="Freshness_Principle.html">Kit Principle</a>
             <li><a href="Freshness_Protocol.html">How It Works</a>
             <li><a href="Case_Studies.html">Case Studies</a>
            <ul><li><a href="Fish_Freshness.html">Fish</a>
             <li><a href="Meat_Freshness.html">Meat</a>    
              </ul></li></ul>
    </li>
    <li><a href="Nucleotide_Analysis_Services.html"><strong>DIETARY<br />
      NUCLEOTIDES</strong></a>
      <ul> 
           <li><a href="Yeast_Extract_Nucleotide_Analysis.html">Yeast Extract</a></li>
            <li><a href="Infant_Formula_Nucleotide_Analysis.html">Infant Formula</a></li>
            <li><a href="Aquaculture_Nucleotide_Analysis.html">Aquaculture Feed</a></li>
             <li><a href="Feed_Nucleotide_Analysis.html">Feed &amp; Pet Food</a></li>
            <li><a href="By-Products_Nucleotides.html">By-Products Valorisation</a></li> 
            </ul>
      </li>
    <li><a href="ATP_Breakdown_Assay_Kit.html"><strong>SLAUGHTER<br />
      NUCLEOTIDES<br />
    </strong></a>	
        <ul>
        <li><a href="ATP_breakdown_salmon.html">Fish </a></li>
        <li><a href="ATP_breakdown_meat.html">Meat</a></li>
        </ul>
    </li>
  </ul>

</div>

<!-- End MENU PRINCIPAL, HORIZONTAL -->





<!-- Sub Menu, Vertical -->
<!-- End Sub Menu, Vertical -->
<br />
<!-- Tax Credit announcement -->
<!-- End Tax Credit announcement -->


<!-- page content -->
   
<div id="content" class=default>
  
  <div align="justify">  
    <!-- Intro -->
    <table width=640>
        <tr>
          <td>
          <h1 class="ChapterThirdTitle">Nucleoside Kinase Enzymes</h1>
            <strong>NOVO</strong><span class="boldRed">CIB</span> produces <strong>human recombinant deoxycytidine kinase,  UMP-CMP kinase (CMK), adenosine kinase and cN-II phosphotransferase</strong>. These enzymes are available in a lyophilized form. <br /><br />
    <!-- Table of NK enzymes -->
    <table align=center border=5 cellpadding=2 cellspacing=0 class=mediumbold>
        <tr bordercolor=#cc0000 align=center>
            <td bordercolor=#f5f5f5 width="104">
            </td>
            <td width="114" align=center ><a href="#AK - Adenosine Kinase" title="Adenosine Kinase" class="boldRedAct"><em>ADK</em> enzyme</a>            </td>
            <td  width="136" align=center><a href="#dCK - Deoxycytidine Kinase" title="Deoxycytidine Kinase" class="boldRedAct"><em>dCK</em> enzyme</a>            </td>
            <td width="141" align=center><a href="#CMK - UMP-CMP Kinase" title="UMP-CMP Kinase" class="boldRedAct"><em>CMK</em> enzyme</a>            </td>
            <td width="105" align=center><a href="#cN-II - 5'nucleotidase" title="5'-nucleotidase" class="boldRedAct"><em>cN-II </em>enzyme</a>            </td>
        </tr>
      	<tr bordercolor=#cc0000>
            <td align=center class="boldRed">Natural substrates
            </td>
            <td valign=top>Adenosine
                <br />Inosine
            </td>
            <td valign=top >Deoxycytidine
                <br />Cytidine
                <br />Deoxyadenosine
                <br />Deoxyguanosine
            </td>
          	<td valign=top>dCMP
                <br />CMP
                <br />UMP
            </td>
            <td valign=top>Deoxyinosine
                <br />Inosine
            </td>
        </tr>
        <tr bordercolor=#cc0000>
			<td align=center class="boldRed">Nucleoside analogues substrates
            </td>
           	<td valign=top>Ribavirin
                <br />Tubercidin
                <br />Mizoribin
            </td>
            <td valign=top>Cladribine
                <br />Fludarabine
                <br />Gemcitabine (dFdC)
                <br />Lamivudine
                <br />Aracytidine (araC)
                <br />Fluorodeoxyuridine
            </td>
            <td valign=top>dFdCMP
                <br /><span class=medium>(Gemcitabine monophosphate)</span>
                <br />3TCMP
                <br />araCMP
                <br /><span class=medium>(Aracytidine monophosphate)</span>
                <br />Adefovir (PMEA)
            </td>
            <td valign=top>Dideoxyinosine
                <br />Ribavirin
                <br />Acyclovir
            </td>
       </tr>
   </table>
   <!-- End Table of NK enzymes -->
   <div align=right>Download our brochure <a href="images/NovoCIB Nucleoside kinases.pdf" target=_blank class="boldRedAct" title="Download our PDF doc">"NovoCIB's Nucleoside kinases"&nbsp;<img width=25 src="images/pdficon_large.gif" /></a></div>    
           </td>
        </tr>
    </table>
    <br />
    
    <!-- End Intro -->
  </div>
  
  <br />
  
  <div id="PrincipalItem">
    <!-- Nucleoside kinases: rate-limiting step of nucleoside analogues activation -->
    <h2 class="ChapterThirdTitle">Nucleoside kinases: rate-limiting step of nucleoside analogues activation</h2>
       
       <div class=default><strong>Nucleoside analogues</strong> have proven to be a highly successful class of anti-cancer and anti-viral drugs. The therapeutic efficacy of nucleoside analogues is dependent of their intracellular phosphorylation. Two cellular nucleoside kinases, <strong>deoxycytidine kinase (dCK)</strong> and <strong>UMP-CMP kinase (CMK)</strong> are critical for the phosphorylation of cytidine analogues. These kinases provide the first two steps of the activation of highly effective anti-cancer and anti-viral drugs, such as 1-&beta;-D-arabinofuranosylcytosine (araC, aracytidine), 2,2difluorodeoxycytidine (dFdC, gemcitabine), and &beta;-D-23-dideoxycytidine (ddC). Both kinases phosphorylate unnatural L-nucleosides (<em>e.g.</em>, &beta;-L-23-dideoxy-3thiacytidine, L-SSdC, 3-TC or lamividune). Kinetic constants of araC, dFdC and 3TC phosphorylation by recombinant dCK and UMP-CMPK have been published. The comparison of phosphorylation properties of new nucleoside analogues with those of known drugs provides the rational basis for <strong>selection of analogues of better therapeutic potential</strong>.
           <br />
           To characterize the phosphorylation properties of new nucleoside analogues, <strong>NOVO</strong><span class="boldRed">CIB</span> has developed <strong>human recombinant dCK</strong> and <strong>human recombinant CMK nucleoside phosphorylation assays</strong>. As shown in Table 1, CMK assay must be performed with monophosphate forms of nucleoside analogues and requires preliminary phosphorylation of nucleoside analogues and their purification. To circumvent this time-consuming step, <strong>NOVO</strong><span class="boldRed">CIB</span> has developed a <strong>coupled dCK-CMK nucleoside phosphorylation assay</strong> which delivers in one step the critical information on both dCK and CMK substrate properties of nucleoside analogue.
           <br /><br />
           <strong>Ribavirin</strong> (1-&beta;-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) is a purine nucleoside analogue with a broad-spectrum antiviral activity. Since the 1970's<span class=medium><sup>(1)</sup></span>, it is known that the initial step of ribavirin (as well as viramidine) phosphorylation is provided by <strong>adenosine kinase (ADK)</strong>. Recently it has been demonstrated that <strong>cytosolic 5-nucleotidase II (cN-II)</strong> can also phosphorylate ribavirin. This could contribute to the development of ribavirin-induced haemolytic anemia <em>in vivo</em><span class=medium><sup>(2)</sup></span>. <strong>NOVO</strong><span class="boldRed">CIB</span> has developed both <strong>human recombinant adenosine kinase (ADK)<strong> and</strong> cytosolic nucleotidase II (cN-II) nucleoside phosphorylation assays</strong> to evaluate the properties of new ribonucleoside analogues in comparison with those of ribavirin.
           <br />
         <br />
           <!-- Bibliography -->
           <table class=small cellSpacing=0 cellPadding=5 align=center>
		       <tr><td valign=top><img src="images/iconsml.gif" width=100/>
                   </td>
			       <td><p><strong>References</strong><br />
                          1. R. C. Willis <em>et al.</em> (1978): Adenosine Kinase Initiates the Major Route of Ribavirin Activation in a Cultured Human Cell Line <em>Proc. Natl. Acad. Sci. USA</em> 75(7), 3042-3044</a><br />
                          2. J. Z. Wu <em>et al.</em> (2005): Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5'-nucleotidase II: Implications for ribavirin metabolism in erythrocytes <em>Antimicrob. Agents Chemother.</em> 49(6), 2164-2171</a><br />
                       </p>
                   </td>
	           </tr>
           </table>
           <!-- End Bibliography -->
       </div>
       
       <div align=right class=medium>Download this document &nbsp;<a href="images/NovoCIB Nucleoside kinases.pdf" target=_blank class="mediumboldRedAct" title="Download our PDF doc">"NovoCIB's Nucleoside kinases"&nbsp;<img width=20 src="images/pdficon_large.gif" /></a>
       </div>
    </p>
    <!-- End Nucleoside kinases: rate-limiting step of nucleoside analogues activation  -->
  </div>
  
  <br />
  
  <div id="PrincipalItem">
    <!-- AK - Adenosine Kinase -->
    <h2><a href="http://www.novocib.com/Recombinant_Adenosine_Kinase" title="Adenosine Kinase" class="ChapterThirdTitle">ADK - Adenosine Kinase (EC 2.7.1.20)</a> </h2>
       <span class="FloatRight"><a href="#top" class="ReturnToTop">(^Top)</a></span>
       <div class="small"><span class="smallbold">Synonyms:</span> ADK, Adenosine 5'-phosphotransferase
       </div>
       <br>
       <div class=default><strong>Adenosine kinase (ADK)</strong> is a ubiquitous enzyme that catalyzes the transfer of gamma-phosphate from ATP to 5-hydroxyl of adenosine, generating AMP and ADP. Adenosine (AR) is an important modulator of central nervous system (CNS) functions with a half-life of seconds. Facilitated diffusion of adenosine across the cell membrane closely couples adenosine concentrations in the intracellular and extracellular compartments. Inhibition of adenosine kinase results in selective increase of local adenosine concentrations and reduced seizure susceptibility and nociception <em>in vivo</em>.
       <br />
       Adenosine kinase is an attractive and experimentally validated target for the development of new analgesic and anti-inflammatory agents. ADK has recently emerged as a novel target to predict and to prevent epileptogenesis.
       <br />
       The X-ray crystallographic structure of human ADK has been described and provides structural basis for rational design and optimisation of new ADK inhibitors.
       <br />
       In addition, this enzyme is responsible for the phosphorylation and consequent clinical activity of several therapeutically useful nucleosides analogues, including the antiviral drug ribavirin, immunosuppressive drug mizoribine, and anticancer C-nucleoside, tiazofurin.
       </div>
       <div align=left><a href="http://www.novocib.com/Recombinant_Adenosine_Kinase" title="Adenosine Kinase" class=mediumboldRedAct>Know more...</a>
       </div>
       </p>
      <!-- End AK - Adenosine Kinase -->
  </div>
  <br />
    
  <div id="PrincipalItem">  
    <!-- dCK - Deoxycytidine Kinase -->
    <h2><a href="http://www.novocib.com/Recombinant_Deoxycytidine_Kinase" class="ChapterThirdTitle">dCK - Deoxycytidine Kinase (EC 2.7.1.74)</a> </h2>
       <span class="FloatRight"><a href="#top" class="ReturnToTop">(^Top)</a></span>
       <div class=default>Human <strong>deoxycytidine kinase (dCK)</strong> plays a key role in the salvage pathway of deoxynucleotides synthesis, providing resting cells with deoxynucleotides for DNA repair and mitochondrial DNA synthesis. The enzyme has a broad substrate specificity and provides the phosphorylation of both purine and pyrimidine deoxynucleosides (<em>e.g.</em> deoxyadenosine (dA), deoxyguanosine (dG)), deoxycytidine (dC), and pyrimidine ribonucleoside, cytidine (C). The enzyme can utilize both ATP and UTP as phosphate donor with UTP being the preferred substrate.
       <br />
       Deoxycytidine kinase is responsible for the phosphorylation and activation of numerous nucleoside analogs used to treat cancer (<em>e.g.</em> cytarabine, gemcitabine, cladribine and fludarabine) including nucleoside analogs of non-physiological L-chirality (<em>e.g.</em> 3TC, lamivudine, anti-HIV, and anti-hepatitis B agent). Three-dimensional structures of dCK in complex with various pyrimidine and purine D- and L-nucleosides have been solved providing structural basis for activation of L- and D-nucleoside analogs.
      </div>
      <div align=left><a href="http://www.novocib.com/Recombinant_Deoxycytidine_Kinase" title="Deoxycytidine Kinase" class=mediumboldRedAct>Know more...</a>
      </div>
    </p>
    <!-- End dCK - Deoxycytidine Kinase -->
  </div>
  
  <br />
    
  <div id="PrincipalItem">  
    <!-- CMK - UMP-CMP Kinase -->
    <h2><a href="http://www.novocib.com/Recombinant_UMP-CMP_Kinase" class="ChapterThirdTitle">CMK - UMP-CMP Kinase (EC 2.7.4.14)</a> </h2>
       <span class="FloatRight"><a href="#top" class="ReturnToTop">(^Top)</a></span>
       <div class="small"><span class="smallbold">Synonyms:</span> cytidylate kinase, deoxycytidylate kinase, cytidine monophosphate kinase (CMK, CMPK), uridine monophosphate kinase (UMK, UMPK), uridine monophosphate / cytidine monophosphate kinase (UCK), UMP/CMP kinase (UMP/CMPK)
       </div>
       <br>
       <div class=default><strong>UMP-CMP kinase (CMK)</strong> plays a critical role in supplying cells with nucleotides by catalysing the phosphorylation of CMP, UMP and dCMP to their respective diphosphate form. CMK plays also an important role in the activation of cytidine analogues, aracytidine and gemcitabine, a mainstay of leukaemia and lymphoma therapy. CMK has a remarkable ability to phosphorylate L-nucleotides from their monophosphate to diphosphate forms as shown for beta-L-23-dideoxy-3thiacytidine (L-SSdC, 3-TC or lamividune), an anti-HIV and anti-hepatitis B drug.
       </div>
       <div align=left><a href="http://www.novocib.com/Recombinant_UMP-CMP_Kinase" title="UMP-CMP Kinase" class=mediumboldRedAct>Know more...</a>
       </div>
    </p>
    <!-- End CMK - UMP-CMP Kinase -->
  </div>
   
  <br />
  
  <div id="PrincipalItem">  
    <!-- cN-II - 5'nucleotidase -->
    <h2><a href="http://www.novocib.com/Recombinant_5'-nucleotidase" class="ChapterThirdTitle">cN-II - cytosolic 5'-nucleotidase II (EC 3.1.3.5)</a></h2>
       <span class="FloatRight"><a href="#top" class="ReturnToTop">(^Top)</a></span>
       <div class="small"><span class="smallbold">Synonyms:</span> cytosolic 5'-nucleotidase/phosphotransferase, High Km 5-nucleotidase (hkm-NT), cytosolic purine 5-nucleotidase (purine 5'-NT), IMP/GMP-specific 5-nucleotidase (IMP/GMP-specific 5'-NT)
       </div>
       <br>
       <div class=default><strong>Cytosolic 5'-nucleotidase II (cN-II)</strong> is one of the seven known mammalian nucleotidases that specifically catalyzes the dephosphorylation of 6-hydroxypurine nucleoside 5-monophosphates (IMP, dIMP, GMP, dGMP) and regulates cellular pool of IMP and GMP. The enzyme also acts as a phosphotransferase catalyzing the transfer of a phosphate from a nucleoside monophosphate to a nucleoside acceptor  preferentially inosine and deoxyinosine. Unlike the other 5-nucleotidases, cN-II is allosterically regulated by adenine/guanine nucleotides and 2,3-biphosphoglycerate.
       <br />Moreover, cytosolic 5'-nucleotidase II phosphorylates anti-viral and anti-tumour nucleoside analogues such as 23-dideoxyinosine, carbovir, acyclovir and ribavirin.
       </div>
       <div align=left><a href="http://www.novocib.com/Recombinant_5'-nucleotidase" title="5'-nucleotidase" class=mediumboldRedAct>Know more...</a>
       </div>
    </p>
    <!-- End cN-II - 5'nucleotidase -->
  </div>
  
  <br />
    
  <div align="center">
    <table border=1 cellspacing=1 bordercolor=#cc0000>
        <tr align="center" bgcolor="#FFCC00" bordercolor=#ffffff>
            <td colspan="2"><span class="big16boldBlack">Related Links</span>
            </td>
        </tr>
        <tr align="left" valign=top bordercolor=#f5f5f5>
            <td class="RelatedLinksBullet">&bull; <a href="http://www.novocib.com/Nucleoside_Kinase_Assay_Kits" class="defaultAct">Nucleoside Kinase Assay Kits</a>
            </td>
           
        </tr>
    </table>
  </div>
</div>
<!-- End page content -->

<!-- Go to Top of Page -->
<div id="GoToTopOfPage"><a href="#Top">^Top of Page</a></div>
<!-- End Go to Top of Page -->

<!-- footer -->
<div id="footer"><br /><SPAN class="Update">Last Update: 2014/04/18</SPAN><SPAN class="Copyright"> &copy; All Right Reserved | Copyright &reg; NovoCIB | N.Godard 2007 | </SPAN><a href="http://www.novocib.com/Legal_Notice" class="Legal" valign=top title="Legal Notice">Legal Notice</a>
</div>
<!-- End footer -->
</div>


<script type="text/javascript">
    initMenu();
</script>

<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-47165485-1', 'novocib.com');
  ga('send', 'pageview');

</script>
</body></html>